Pfizer and BioNTech to Provide 500 million doses of COVID-19 vaccine to U.S. Government fir Donation to Poorest Nations
British Reporter — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022, to further support the multilateral efforts to address the surge of infection in
Latest comments